Innovative Therapy Changes Brain Activity
Transcranial Magnetic Stimulation (TMS) is an innovative therapy for those
who have moderate to severe depression that have had trouble responding to
medication. TMS works by using magnetic fields to increase or reduce
specific brain activity. Using TMS allows doctors to change brain activity
without surgery and with minimal discomfort to the patient.
We conducted the first double blind clinical trial of TMS in depression and
in our clinical program have successfully treated hundreds of patients.
Patients can derive a sustained improvement in their depression, becoming
able to have fulfilling lives.
Approved by the U.S. Food and Drug Administration (FDA)
The FDA has cleared the NeuroStar Transcranial Magnetic Stimulation Therapy
System for use in those suffering from medication-resistant depression.
Beth Israel Deaconess is proud to have been the first to offer this
therapy to patients in the Boston area.
Reduction in Depression Symptoms
In clinical studies, approximately half of patients treated with NeuroStar
TMS Therapy responded. These patients experienced an average reduction in
their depression symptoms that was more than twice the average in those
receiving an inactive treatment. More importantly, individual patients can
show striking benefits with complete resolution of the depression and
practically no side effects.
For Other Indications
TMS and tDCS can be applied to different brain areas with the goal of
treating other conditions. Research is ongoing to determine whether these
techniques are effective to treat chronic pain, epilepsy and tinnitus. The
Food and Drug Administration (FDA) has not yet approved the use of TMS or
tDCS for these conditions. However, TMS and tDCS can be used as "off-label"
treatments, though they are considered investigational (not proven). As
such, for any of these treatment indications, we do a complete neurological
evaluation with all prospective patients to ensure there are no safety
contraindications, and acquire informed consent to ensure that all patients
are aware that the treatments are considered off-label.